SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950103-05-001330
Filing Date
2005-05-02
Accepted
2005-05-02 14:16:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 may0205_13d.htm SC 13D 49027
  Complete submission text file 0000950103-05-001330.txt   50905
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-47221 | Film No.: 05789771
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address HAMPSHIRE INTL BUSINESS PARK CHINEHAM BASINGSTOKE HAMPSHIRE ENGLAND RG X0
Business Address HAMPSHIRE INTL BUSINESS PARK CHINEHAM BASINGSTOKE HAMPSHIRE ENGLAND RG X0 1264333455
SHIRE PHARMACEUTICALS GROUP PLC (Filed by) CIK: 0000936402 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations